MDCG has published guidance MDCG 2020-12 on transitional provisions for consultations of authorities on devices incorporating a substance, which may be considered a medicinal product […] as well as on devices manufactured using TSE susceptible animal tissues.
Read it here: Text for Guidance MDCG-12
Also check out the FDA Combination Products Guidance here
Classification and regulatory management of these products could actually forestall a Manufacturer’s operations unless properly identified. Contact Evnia for tailored resources on drug-device combination products that will accelerate your compliance with Regulations!
Download the file in .pdf format from here
Evnia offices will be closed until January 3rd for Christmas!
December 19, 2024
